In the weeks and months following the May 20, 2022, recall of Jif peanut butter products, the US Food and Drug Administration (FDA) received more than 200 reports from consumers complaining of illness after consuming the recalled products.
This information was supplied to eFoodAlert by the FDA in response to a Freedom of Information Act request.
It is usual for an outbreak of foodborne illness to be significantly larger than indicated by CDC statistics. Indeed, the CDC reminded the public of this in its investigation report, saying, “The true number of sick people in this outbreak was likely much higher than the number reported. This is because many people recover without medical care and are not tested for Salmonella.”
By the numbers
The CDC tally
The CDC received lab-confirmed reports of outbreak cases in 21 individuals from 17 different states. Four people were hospitalized.
- The first victim (“Patient Zero”) became ill on February 19, 2022.
- The 21st victim became ill on May 23, 2022.
- The youngest victim was less than one year old.
- The oldest victim was 85 years old.
- The median age of the victims was 59 years.
- 75% of the victims were female.
- 100% of the victims interviewed reported having consumed Jif peanut butter in the days before becoming ill.
The FDA tally
From January 1, 2022, through October 11, 2022, the FDA fielded a total of 320 queries and complaints relating to Jif peanut butter. Of these, 319 were specifically related to products manufactured at the Lexington, Kentucky, manufacturing plant linked to the outbreak.
- 235 of the complainants reported having suffered an illness after consuming Jif peanut butter
- 204 of the complainants reported specific symptoms; the remaining 31 reports mentioned “illness” or “adverse events”
- Most of the individuals who reported symptoms suffered from multiple ill effects, including:
- diarrhea: 166
- cramps or abdominal pain: 124
- vomiting: 80
- nausea: 67
- fever or chills: 63
- Weakness, lethargy or fatigue: 33
- headache: 31
- Fainting, disorientation, dizziness, brain fog: 10
- 8 reported bloody diarrhea
- 4 reported a confirmed Salmonella diagnosis
- 2 suffered from colitis
- 2 suffered sepsis (a potentially serious, more generalized infection)
- 1 individual reported a perforated bowel and peritonitis
- 1 reported kidney failure
On May 20, 2022, The J.M. Smucker Co. announced a voluntary recall of peanut butter manufactured at its Lexington, Kentucky, production facility during a period of several months, up to and including the recall date.
The recall notice listed a variety of products and packaging formats from individual serving size packets weighing less than one ounce to 96-ounce twin packs, including:
- JIF CREAMY PEANUT BUTTER: 5,859,227 cases
- JIF CRUNCHY PEANUT BUTTER: 1,567,672 cases
- JIF NATURAL CRUNCHY PEANUT BUTTER: 196,694 cases
- JIF 12 OUNCE CRUNCHY PEANUT BUTTER INTERNATIONAL: 750 cases
- JIF 3/4 OUNCE PEANUT BUTTER PLASTIC CASE: 549,884 cases
- JIF NATURAL PEANUT BUTTER: 47,918 cases
- JIF NATURAL CREAMY PEANUT BUTTER: 553,007 cases
- JIF 33.5 OUNCE NO ADDED SUGAR CREAMY PEANUT BUTTER: 67,504 cases
- JIF 13 OUNCE NATURAL CREAMY PEANUT BUTTER SQUEEZE POUCH: 41,297 cases
- JIF REDUCED FAT CREAMY PEANUT BUTTER: 454,971 cases
- JIF 16 OUNCE NATURAL CREAMY PEANUT BUTTER HONEY: 77,075 cases
- JIF NO ADDED SUGAR PEANUT BUTTER: 115,106 cases
- JIF 1.5 oz and 31.25 gram CREAMY PEANUT BUTTER TO GO: 1,420,560 cases
- JIF 340 GRAM CREAMY PEANUT BUTTER MEXICO: 20,021 cases
- JIF 454 GRAM CRUNCHY PEANUT BUTTER MEXICO: 7,460 cases
- JIF 454 GRAM REDUCED FAT CREAMY PEANUT BUTTER MEXICO: 2,880 cases
- JIF 16 OUNCE CREAMY OMEGA 3 PEANUT BUTTER: 33,516 cases
- JIF 40 OUNCE CRUNCHY PEANUT BUTTER: 402,038 cases
- JIF LIGHT CREAMY PEANUT BUTTER: 1,815 cases
- JIF 1.5 oz CRUNCHY PEANUT BUTTER TO GO: 29,117 cases
- JIF 1.5 oz NATURAL CREAMY PEANUT BUTTER TO GO: 330,528 total cases
- JIF DARK ROAST CREAMY PEANUT BUTTER: 23,635 cases
As of October 21, 2022, the recall has not been completed.
CDC versus FDA reporting
The differences between the data reported by the FDA and the CDC are a function of how the two agency systems operate.
The CDC relies on reports of lab-confirmed cases of foodborne illness, and reports only on those cases, whereas the FDA receives and tabulates complaints from consumers, regardless of whether or not there was lab confirmation of an infection.
Both systems provide useful and complementary information that enables epidemiologists to determine the scope of an outbreak and–with a bit of luck thrown in to season the pot–trace it to its source.
In fact, it is likely that the number of people affected by the contaminated peanut butter was far larger even than the 200+ individuals reported by the FDA. There is no way of knowing how many people suffered mild symptoms and either didn’t realize they were linked to a Jif product or didn’t bother making a report.
The consequences for the company
In 2006, Peter Pan peanut butter manufactured by ConAgra was responsible for an outbreak of 425 Salmonella infections. An FDA inspection revealed that the company had been aware of a Salmonella contamination problem in their production plant, but did not reveal this information to the FDA investigation team. The government laid charges against ConAgra and entered into a plea agreement with the company in 2015. ConAgra pled guilty to a criminal misdemeanor, was fined $8 million, and had to forfeit an additional $3.2 million in assets.
In 2009, Peanut Corporation of America was responsible for a deadly outbreak of Salmonella infections that sickened 714 people and killed nine of them. Company management had knowingly shipped contaminated peanut butter to its customers. Once again, the government brought criminal charges. This time, the owners received prison sentences.
In 2012, Sunland Inc., the largest producer of organic peanut butter in the USA, was the source of a Salmonella outbreak that sickened 42 people. Again, the coupany was found to have knowingly shipped contaminated product. The FDA suspended Sunland’s food facility registration, effectively shutting down the company’s operations, but no charges were laid.
Earlier today, the FDA declined eFoodAlert’s request for a copy of the Jif Establishment Inspection Report on the basis that, “…disclosure could reasonably be expected to interfere with enforcement proceedings.”
The FDA has a range of possible enforcement proceedings at its disposal, ranging from a simple Warning Letter all the way up to referring the case to the Department of Justice for the laying of criminal charges.
Watch this space…
Read more about Salmonella in peanut butter in TAINTED. From Farm Gate to Dinner Plate, Fifty Years of Food Safety Failures, now available in digital, print and audiobook editions.